CIBC Private Wealth Group LLC Grows Stake in The Cooper Companies, Inc. (NASDAQ:COO)

CIBC Private Wealth Group LLC increased its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 27.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 25,627 shares of the medical device company’s stock after purchasing an additional 5,589 shares during the period. CIBC Private Wealth Group LLC’s holdings in Cooper Companies were worth $2,355,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Fulton Bank N.A. increased its holdings in shares of Cooper Companies by 3.0% in the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock worth $342,000 after purchasing an additional 109 shares during the last quarter. Torray Investment Partners LLC raised its holdings in shares of Cooper Companies by 0.8% during the 4th quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company’s stock worth $1,488,000 after acquiring an additional 132 shares in the last quarter. Mather Group LLC. boosted its position in shares of Cooper Companies by 7.4% during the 4th quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock valued at $177,000 after acquiring an additional 133 shares during the last quarter. MassMutual Private Wealth & Trust FSB grew its holdings in shares of Cooper Companies by 15.6% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock valued at $93,000 after purchasing an additional 136 shares in the last quarter. Finally, Greenleaf Trust grew its holdings in shares of Cooper Companies by 5.0% in the fourth quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock valued at $268,000 after purchasing an additional 139 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Stock Down 0.0 %

Shares of NASDAQ COO opened at $81.23 on Thursday. The Cooper Companies, Inc. has a 52-week low of $77.05 and a 52-week high of $112.38. The firm has a market capitalization of $16.24 billion, a price-to-earnings ratio of 41.66, a PEG ratio of 2.25 and a beta of 1.02. The stock has a 50 day moving average price of $88.59 and a 200 day moving average price of $96.72. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting the consensus estimate of $0.92. The business had revenue of $964.70 million during the quarter, compared to analysts’ expectations of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Sell-side analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research firms have commented on COO. BNP Paribas upgraded shares of Cooper Companies to a “hold” rating in a research report on Thursday, March 13th. StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research note on Friday, March 7th. Wells Fargo & Company raised their price objective on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. Finally, Robert W. Baird cut their target price on Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a research report on Friday, March 7th. Four analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $110.25.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.